RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells.

Patel H, Mishra R, Wier A, Mokhtarpour N, Merino EJ, Garrett JT
Anticancer Drugs. 2023 Apr 1;34(4):519-531. doi: 10.1097/CAD.0000000000001500. Epub 2023 Feb 10. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.